Home Search
epinephrine auto-injector - search results
If you're not happy with the results, please do another search
Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen
Nasal epinephrine powder shows significant potential for treating anaphylaxis, surpassing the efficacy of traditional EpiPens in trials.
How a Stranger and Cabin Crew Saved a Man’s Life Mid-Flight with a Second...
Learn why it is imperative to always carry a 2nd dose of epinephrine.
Aquestive Works with FDA to Resolve Hurdles for its New Sublingual Epinephrine Candidate
Understand the implications of the FDA's findings on sublingual epinephrine and its journey towards approval and market release.
FDA Calls for “Creative” Proposals to Make Epinephrine Available Over-the-Counter
The FDA signals openness to designating epinephrine OTC with caveats.
States That Currently Cap Epinephrine Costs as of January 1, 2026
Does your state cap out-of-pocket costs for epinephrine? Find the details here.
New York Limits Epinephrine Costs as Landmark Insurance Law Takes Effect
Correction: the title and content of this article have been updated to reflect that other modes of epinephrine delivery, in addition to auto-injectors, are...
Nasus Doses First Patient in Phase 2 Trial of Powder-Based Intranasal Epinephrine for Anaphylaxis
A critical step in the development of another needle-free nasal spray alternative to traditional epinephrine auto-injectors
Anaphylm™ Sublingual Epinephrine Shows Promising Results for Pediatric Anaphylaxis Treatment
Aquestive's phase 1 study of AQST-109, shows promising results as a new, easy-to-use option for treating severe allergic reactions like anaphylaxis.
Parents Turn Son’s Tragedy Into Advocacy, Meet with Legislators to Promote Epinephrine Law
Parents are working to ensure that first responders are equipped with epinephrine to handle life-threatening anaphylaxis.
Another Needle-Free Emergency Epinephrine Candidate to Begin Clinical Trials
Powder-based intranasal device demonstrates superior heat stability.
Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.
We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.
Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.
Please see our Terms of Service and Privacy Policy.
Copyright ©2011-2024 SnackSafely.com, Inc — All rights reserved